Home
CrystalGenomics

CrystalGenomics Market Share Analysis for June 2026

Health > Biotechnology and Pharmaceuticals

Domaincrystalgenomics.com

Year Founded2000

Employees51 - 200

Annual Revenue$10M - $15M

CrystalGenomics

CrystalGenomics (including company regionals)

crystalgenomics.com

See more website traffic and engagement information

CrystalGenomics Revenue up to June 2026 is 10M - 15M

revenue generated by CrystalGenomics top domains

CrystalGenomics top domains revenue over 3 years

Revenue for CrystalGenomics top domains

crystalgenomics.com10M - 15M

See more with Sales Intelligence

Total visits to CrystalGenomics's top domains

Understand CrystalGenomics market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in CrystalGenomics's top domains

Analyze CrystalGenomics engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on CrystalGenomics's top domains

See how CrystalGenomics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

CrystalGenomics top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by CrystalGenomics

These are the website technologies, by industry, used by CrystalGenomics top domains

Advertising (1)

PubMatic

Conversion & Analytics (1)

Google Analytics

eCommerce (1)

Cafe24 Nameserver

Email Services (1)

G Suite

More Technologies

4

See all

News & Signals from CrystalGenomics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsDaewoong Pharmaceutical partnered with CrystalGenomics, Inc. on Feb 25th '21.Some said Daewoong might have teamed up with Crystal Genomics to release the generic drug because Crystal Genomics had proposed Acelex contract manufacturing to local drug companies last year.

NewsCrystalGenomics, Inc. hired Gavin Choy as president on Oct 8th '20.CrystalGenomics, Inc. (KOSDAQ: 083790), a commercial stage biopharmaceutical company that is dedicated to the discovery, development and commercialization of novel therapeutics in unmet medical need areas of inflammation, oncology, and infectious disease, today announced the appointment of Gavin Choy, PharmD, MBA as President of CG Pharmaceuticals, Inc., CrystalGenomics' subsidiary focused on the clinical development of novel therapeutics.

NewsAptose Biosciences, Inc. partnered with CrystalGenomics, Inc. on Jun 14th '18.In June, Aptose entered into a separate license agreement with CrystalGenomics, Inc., providing Aptose with the China rights to CG-806 (including People’s Republic of China, Hong Kong and Macau ).